ICU Medical (ICUI) Stock Price, News & Analysis

Company Overview

ICU Medical, Inc. develops, manufactures and sells medical devices used in infusion therapy, critical care and oncology. Its product portfolio includes infusion pumps, IV administration sets, needle-free connectors, vascular access devices, patient monitoring equipment and related accessories designed to support the delivery of fluids and medications and the monitoring of patients in healthcare settings.

The company also provides products for the safe handling of hazardous drugs, including closed-system transfer devices used in oncology and pharmacy operations. Its offerings are used by hospitals, ambulatory care centers, pharmacies and other healthcare providers, with products sold in the United States and international markets through direct sales organizations and distributors.

Founded in 1984, ICU Medical is headquartered in San Clemente, California. The company expanded its infusion therapy business through the acquisition of Smiths Medical, completed in 2022, adding infusion systems, vascular access products and other medical technologies to its portfolio. Vivek Jain serves as the company’s chief executive officer.

Key Stats

• Today's Range: $155.74 to $158.68
• 50-Day Range: $151.89 to $187.26
• 52-Week Range: $112.50 to $192.85
• Volume: 189,258 shs
• Average Volume: 221,317 shs
• Market Capitalization: $3.94 billion
• P/E Ratio: 133.56
• Dividend Yield: N/A
• Price Target: $192.80
• Consensus Rating: Moderate Buy

ICU Medical Stock Analysis - MarketRank™

ICU Medical scored higher than 80% of companies evaluated by MarketBeat, and ranked 129th out of 903 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 4.2 / 5
• Analyst Rating: Moderate Buy

Consensus Rating

ICU Medical has received a consensus rating of Moderate Buy. The company's average rating score is 2.89, and is based on 2 strong buy ratings, 4 buy ratings, 3 hold ratings, and no sell ratings.

Upside Potential

ICU Medical has a consensus price target of $192.80, representing about 22.3% upside from its current price of $157.60.

Amount of Analyst Coverage

ICU Medical has been the subject of 7 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

Earnings and Valuation

• Score: 1.9 / 5
• Proj. Earnings Growth: 10.57%

Earnings Growth

Earnings for ICU Medical are expected to grow by 10.57% in the coming year, from $7.19 to $7.95 per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of ICU Medical is 133.56, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 38.99.

Price to Earnings Ratio vs. Sector

The P/E ratio of ICU Medical is 133.56, which means that it is trading at a less expensive P/E ratio than the Healthcare sector average P/E ratio of about 273.30.

Price to Earnings Growth Ratio

ICU Medical has a PEG Ratio of 1.98. PEG Ratios above 1 indicate that a company could be overvalued.

Price to Book Value per Share Ratio

ICU Medical has a P/B Ratio of 1.83. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

Short Interest

• Score: 1.0 / 5
• Short Interest Level: Bearish

Percentage of Shares Shorted

5.86% of the float of ICU Medical has been sold short.

Short Interest Ratio / Days to Cover

ICU Medical has a short interest ratio ("days to cover") of 6.74.

Change versus previous month

Short interest in ICU Medical has recently increased by 3.53%, indicating that investor sentiment is decreasing.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

ICU Medical does not currently pay a dividend.

Dividend Growth

ICU Medical does not have a long track record of dividend growth.

News and Social Media

• Score: 4.2 / 5
• News Sentiment: 1.67

News Sentiment

ICU Medical has a news sentiment score of 1.67. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.85 average news sentiment score of Healthcare companies.

News Coverage This Week

MarketBeat has tracked 6 news articles for ICU Medical this week, compared to 3 articles on an average week.

MarketBeat Follows

1 people have added ICU Medical to their MarketBeat watchlist in the last 30 days.

Company Ownership

• Score: 1.5 / 5
• Insider Trading: Selling Shares

Insider Buying vs. Insider Selling

In the past three months, ICU Medical insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $3,905,003.00 in company stock.

Percentage Held by Insiders

2.10% of the stock of ICU Medical is held by insiders.

Percentage Held by Institutions

96.10% of the stock of ICU Medical is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

Company Calendar

• Last Earnings: 8/06/2026
• Today: 9/14/2026
• Barclays 24th Annual Global Financial Services Conference: 9/15/2026
• Morgan Stanley 24th Annual Global Healthcare Conference: 9/15/2026
• Next Earnings (Estimated): 11/05/2026
• Fiscal Year End: 12/31/2026

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Healthcare
• Industry: Healthcare Equipment & Supplies
• Sub-Industry: Healthcare Supplies
• Current Symbol: NASDAQ:ICUI
• CIK: 883984
• Web: www.icumed.com
• Phone: (949) 366-2183
• Fax: 949-366-8368
• Employees: 13,000
• Year Founded: 1984

Price Target and Rating

• Average Price Target for ICU Medical: $192.80
• High Price Target: $200.00
• Low Price Target: $182.00
• Potential Upside/Downside: +22.3%
• Consensus Rating: Moderate Buy
• Rating Score (0-4): 2.89
• Research Coverage: 9 Analysts

Profitability

• EPS (Trailing Twelve Months): $1.18
• Trailing P/E Ratio: 133.56
• Forward P/E Ratio: 21.92
• P/E Growth: 1.98
• Net Income: $730 thousand
• Net Margins: 1.39%
• Pretax Margin: 0.03%
• Return on Equity: 7.91%
• Return on Assets: 4.17%

Debt

• Debt-to-Equity Ratio: 0.56
• Current Ratio: 2.43
• Quick Ratio: 1.21

Sales & Book Value

• Annual Sales: $2.23 billion
• Price / Sales: 1.77
• Cash Flow: $14.69 per share
• Price / Cash Flow: 10.73
• Book Value: $86.03 per share
• Price / Book: 1.83

Miscellaneous

• Outstanding Shares: 24,990,000
• Free Float: 24,469,000
• Market Cap: $3.94 billion
• Optionable: Optionable
• Beta: 0.75